Linex caps. # 32 blisters
Package quantity, pcs:
7
14
16
32
Dosage:
5.04mg
60mg
Scope of the drug
Gastrointestinal tract
Release form
Capsules
Manufacturer country
Slovenia
Package quantity, pcs
32
Scope of application
Gastroenterology
Release form, composition and packaging
?
The capsules are opaque, with a white body and a lid
contents - white powder, odorless.
1 caps.
Lebenin® 280 mg
(1 g of active ingredient Lebenin®, powder contains: Lactobacillus acidophilus (species L. gasseri) - 300 mg, Bifidobacterium infantis - 300 mg, Enterococcus faecium - 300 mg, lactose - 50 mg, potato starch - 50 mg) magnesium stearate - 8.4 mg.
The composition of the capsule shell: methyl hydroxybenzoate - 0.19 mg, propyl hydroxybenzoate - 0.08 mg, titanium dioxide (E171) - 0.98 mg, gelatin - up to 63 mg.
8 pcs.
- blisters made of soft aluminum / hard aluminum foil (Al / Al) (2) - cardboard packs.
8 pcs.
- blisters made of soft aluminum / hard aluminum foil (Al / Al) (4) - cardboard packs.
8 pcs.
- blisters made of soft aluminum / hard aluminum foil (Al / Al) (6) - cardboard packs.
pharmachologic effect
A drug that normalizes the intestinal microflora. One capsule of the drug contains at least 1.2 × 107 live lyophilized lactic acid bacteria: Lactobacillus acidophilus, Bifidobacterium infantis, Enterococcus faecium. Live lactic acid bacteria are a normal component of the natural intestinal microflora and are already present in the digestive tract of the newborn. The bifidobacteria, lactobacilli and enterococci included in the Linex® preparation cause a shift in intestinal pH to the acidic side due to lactose fermentation, while the acidic environment inhibits the growth of pathogenic and opportunistic bacteria and ensures the optimal action of digestive enzymes participate in the synthesis of vitamins B, K, ascorbic acid, thereby increasing the body's resistance to adverse environmental factors participate in the metabolism of bile acids and bile pigments synthesize substances with antibacterial activity increase the body's immune reactivity.
Pharmacokinetics
Pharmacokinetic data not provided.
Indications for use
- treatment and prevention of dysbiosis.
Dysbacteriosis is manifested by diarrhea, dyspepsia, constipation, flatulence, nausea, vomiting, belching, abdominal pain
allergic reactions are possible.
Contraindications for use
- hypersensitivity to any of the components of the drug or to dairy products.
Dosage regimen
The drug is prescribed orally after meals, the capsules should be taken with a small amount of liquid.
Children under 3 years of age and patients who cannot swallow the capsule should open it, pour the contents into a spoon and mix with a small amount of liquid.
Newborns and children under the age of 2 years are prescribed 1 capsule 3 times / day.
Children aged 2 to 12 years - 1-2 capsules 3 times / day.
Adults and children over 12 years of age are prescribed 2 capsules 3 times / day.
The duration of treatment depends on the cause of the development of dysbiosis and the individual characteristics of the organism.
Overdose
Currently, no cases of an overdose of Linex® have been reported.
Side effect
The drug is well tolerated.
There are no data on adverse reactions, however, the possibility of developing hypersensitivity reactions cannot be ruled out.
Drug interactions
No undesirable interactions of Linex® with other drugs were noted.
The composition of Linex® allows you to take it simultaneously with antibiotics and chemotherapeutic agents.
Application during pregnancy and lactation
Use during pregnancy and lactation is considered safe.
Special instructions It is not recommended to drink Linex® with hot drinks and take it simultaneously with alcohol.
The patient should consult a doctor if, before taking the drug, he has a body temperature above 38 ° C, there is blood or mucus in the stool, diarrhea lasts more than 2 days and is accompanied by acute abdominal pain, dehydration and weight loss, in the presence of chronic
Name ENG
LINEX FORTE
Clinical and pharmacological group
A drug that regulates the balance of intestinal microflora (probiotic)
ATX code
Preparations containing microorganisms that produce lactic acid in combination with other drugs
Dosage
5.04mg
Structure
1 capsule contains: active ingredient: Lebenin?
280.00 mg (in 1 g of active ingredient Lebenin, powder contains: Lactobacillus acidophilus (species L. gasseri) - 300 mg, Bifidobacterium infantis - 300 mg, Enterococcus faecium - 300 mg, lactose - 50 mg, potato starch - 50 mg)
excipients: magnesium stearate?
8.40 mg
capsule shell?
methylhydroxybenzoate?
0.19 mg, propyl hydroxybenzoate?
0.08 mg, titanium dioxide (E171)?
0.98 mg, gelatin?
up to 63.0 mg.
Indications
treatment and prevention of intestinal dysbiosis.
Intestinal dysbiosis is manifested by the following symptoms: diarrhea, dyspepsia, constipation, flatulence, nausea, belching, vomiting, abdominal pain, allergic skin reactions are possible.
relief of constipation in adults and children over 12 years of age
addition to standard eradication therapy of Helicobacter pylori in adults and children over 12 years old.
Contraindications
hereditary fructose intolerance, sucrase-isomaltase deficiency or glucose / galactose malabsorption syndrome
hypersensitivity to drug components.
The drug should be used with caution in diabetes mellitus (it contains simple sugars), deficiency of the immune system (for example, HIV infection).
Storage conditions and periods
At a temperature not exceeding 25 degrees, in the original packaging.
Expiration date: 2 years
INN / Active ingredient
Lactobacillus acidophilus, Bifidobacterium animalis subsp.
lactis
Specifications
Scope of the drug
Gastrointestinal tract
Release form
Capsules
Manufacturer country
Slovenia
Package quantity, pcs
32
Scope of application
Gastroenterology
Minimum age from
From birth
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Sandoz
The amount of the dosage form in the primary package
8 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Eubiotic
Dosage form
Capsules
The target audience
Adult
Dosage (volume) of the substance in the preparation
Active Ingredient: Lebenin?
280.00 mg
Expiration date in days
730
Package weight, g
thirty
Category
:
Preparations for the gastrointestinal tract
,
Dysbacteriosis
,
Probiotics and prebiotics
,
Inulins
Mode of application
:
Inside. < br> Linex should be taken after meals with a small amount of liquid.
For children under 3 years old and patients who cannot swallow a whole capsule, it must be opened, pour the contents into a spoon and mix with a small amount of liquid.
< br> Newborns and children under 2 years of age: 1 capsule 3 times a day
< br> Children from 2 to 12 years old: 1-2 capsules 3 times a day < br> Adults and adolescents over 12 years old: 2 capsules 3 times a day.
The duration of treatment depends on the cause of the development of dysbiosis and the individual characteristics of the organism.
Anatomical and therapeutic characteristics
:
A07FA51 Microorganisms producing lactic acid, in combination with other drugs
Information on technical characteristics, delivery set, country of manufacture